InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by LUCIER GREGORY T, Director. Director active across 5 companies, notably Maravai Lifesciences Holdings, INC.. Aggregated, 28 disclosures have been recorded. Total volume traded: €2.4m. The latest transaction was filed on 5 December 2025 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations28 total
US$163,57451,472 shares@ US$3.17790.035% mcap100.0% of flow
Class A Common Stock
SEC:0001251299-25-000004·
Ideal exit: 1 Sept 2026 (T+270)
€163,57451,472 shares@ €3.17790.035% mcap50.0% of flow
Class A Common Stock
SEC:0001251299-25-000004:0·
Ideal exit: 1 Sept 2026 (T+270)
07.609 shares0
Common Stock
SEC:0001127602-22-011852:0·
016,666 shares0
Common Stock
SEC:0001567619-22-007365:0·
€238,09850,000 shares@ €4.76216.5% of flow
Common Stock
SEC:0001567619-22-007008:0·
Ideal exit: 6 Dec 2022 (T+270)
05.952 shares0
Common Stock
SEC:0001127602-22-007229:0·
€301,3512,668 shares@ €112.95100.0% of flow
Common Stock
SEC:0001596783-21-000192·
€301,3512,668 shares@ €112.9550.0% of flow
Common Stock
SEC:0001596783-21-000192:0·
04,271 shares0
Class A Common Stock
SEC:0000899243-21-045771·
04,271 shares0
Class A Common Stock
SEC:0000899243-21-045771:0·
€432,70720,704 shares@ €20.899771.9% of flow
Common Stock
SEC:0001567619-21-019589·
Ideal exit: 2 Aug 2022 (T+270)
€432,70720,704 shares@ €20.899730.0% of flow
Common Stock
SEC:0001567619-21-019589:0·
Ideal exit: 2 Aug 2022 (T+270)
01,402 shares0
Common Stock
SEC:0001596783-21-000174·
01,402 shares0
Common Stock
SEC:0001596783-21-000174:0·
€2875.523 shares@ €51.91290.0000% mcap50.7% of flow
Common Stock
SEC:0001127602-21-026972·
€2875.523 shares@ €51.91290.0000% mcap25.3% of flow
Common Stock
SEC:0001127602-21-026972:0·
€2795.156 shares@ €54.16950.0000% mcap49.3% of flow
Common Stock
SEC:0001127602-21-021893·
€2795.156 shares@ €54.16950.0000% mcap24.7% of flow
Common Stock
SEC:0001127602-21-021893:0·
€169,4475,000 shares@ €33.889428.1% of flow
Common Stock
SEC:0001567619-21-011783·
Ideal exit: 28 Feb 2022 (T+270)
€169,4475,000 shares@ €33.889411.7% of flow
Common Stock
SEC:0001567619-21-011783:0·
Ideal exit: 28 Feb 2022 (T+270)
03,008 shares0
Common Stock
SEC:0001127602-21-018522·
03,008 shares0
Common Stock
SEC:0001127602-21-018522:0·
019,125 shares0
Common Stock
SEC:0001209191-21-034566·
019,125 shares0
Common Stock
SEC:0001209191-21-034566:0·
01,400 shares0
Common Stock
SEC:0001567619-21-010674·
25 of 28 declarations
About LUCIER GREGORY T
Gregory T Lucier is a director at Maravai Lifesciences Holdings, Inc.
